Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Contact information


harindra.amarasinghe@well.ox.ac.uk

Harindra Amarasinghe

Postdoctoral Scientist

I completed my PhD on epigenetics and the evolution of genomic imprinting at the Department of Genetics and Genome Biology (University of Leicester). I then joined the School of Cancer Sciences of the University of Southampton as a Postdoctoral Research Fellow where I investigated the clinical utility of genetic and epigenetic biomarkers in treating Chronic Lymphocytic Leukaemia patients entered into first-line chemotherapy and chemo-immunotherapy in UK CLL clinical trials.

I joined the Knight group in 2018 and my project explored the role functional genomics play in extreme immunity, with a particular emphasis on immune tolerance, and targeted identification of therapeutic options using a combination of multi-omic approaches.

Currently, I work as a senior scientist in the Knight group on a collaborative project led by Julian Knight and Marian Knight on advancing personalised maternal healthcare using genomic-based approaches alongside epidemiological studies.